Fueling the Viral Fire With mRNA

John Catanzaro
2 min readJan 2, 2021

--

2021 John A. Catanzaro, CEO of Neo7Logix

In the next few months to years, the existing trend of mRNA vaccines will reveal the shortfalls associated with their current designs. Currently, greater than 60% of the population affected by the COVID global outbreak are refusing the mRNA-based vaccines over concerns of safety and long-term adverse health effects.

--

--

John Catanzaro

John A. Catanzaro is CEO of Neo7logix, a bioscience company that designs precision and personalized treatment designs. www.neo7logix.com